Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

NCT04498117 · clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
615
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CanariaBio Inc.

Collaborators